{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T20:53:30Z","timestamp":1786136010239,"version":"build-2736575974"},"reference-count":54,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"32","license":[{"start":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T00:00:00Z","timestamp":1786060800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,8,7]]},"abstract":"<jats:sec>\n                    <jats:title\/>\n                    <jats:p>This study investigates the potential mechanisms through which the Rhubarb\u2013Peach Kernel herb pair may exert effects in gastric cancer (GC) using network pharmacology and molecular docking approaches. Active compounds and their corresponding targets were retrieved from the Traditional Chinese Medicine Systems Pharmacology Database and Analysis Platform (TCMSP), with additional compound\u2013target information obtained from DrugBank. Gastric cancer-related targets were collected from GeneCards, Online Mendelian Inheritance in Man (OMIM), the Therapeutic Target Database, and DrugBank. The overlapping targets were used to construct a compound\u2013target\u2013disease network and a protein\u2013protein interaction network. Gene ontology and Kyoto Encyclopedia of Genes and Genomes pathway enrichment analyses were subsequently performed. Nine candidate compounds were docked against 8 core targets to assess their predicted structural interactions. A total of 27 active compounds were identified, among which \u03b2-sitosterol, aloe-emodin, and hederagenin were identified as major candidate compounds. Tumor protein p53, caspase 3, and JUN were among the principal network targets. Enrichment analysis indicated that the overlapping targets were mainly associated with the p53 signaling pathway and other pathways involved in cancer-related processes, including apoptosis, cell survival, and inflammatory regulation. Molecular docking revealed differences in predicted binding scores among the 9 candidate compounds and 8 core targets, with several compound\u2013target pairs showing comparatively lower docking energies. This in silico study suggests that the Rhubarb\u2013Peach Kernel herb pair may act through multiple compounds, targets, and biological pathways relevant to GC. However, the identified targets are not necessarily specific to GC, and the molecular docking findings represent computational predictions rather than evidence of actual biological binding. These results should therefore be considered preliminary and hypothesis-generating, and further in vitro and in vivo studies are required to evaluate their biological and therapeutic relevance.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/md.0000000000050153","type":"journal-article","created":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T18:01:35Z","timestamp":1786125695000},"page":"e50153","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Mechanisms of Rhubarb\u2013Peach Kernel in treating gastric cancer: A network pharmacology and molecular docking study"],"prefix":"10.1097","volume":"105","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-1708-5580","authenticated-orcid":false,"given":"Jiatian","family":"Chen","sequence":"first","affiliation":[{"name":"Department of Oncology, Putuo Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manli","family":"Xie","sequence":"additional","affiliation":[{"name":"Department of Oncology, Putuo Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinquan","family":"Zhou","sequence":"additional","affiliation":[{"name":"Department of Tuina, Pinghu Hospital of Traditional Chinese Medicine, Pinghu, Zhejiang, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoxiao","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Oncology, Putuo Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20260807","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/S0140-6736(20)31288-5","article-title":"Gastric cancer.","volume":"396","author":"Smyth","year":"2020","journal-title":"Lancet"},{"key":"R2-20260807","doi-asserted-by":"crossref","first-page":"2452","DOI":"10.3748\/wjg.v29.i16.2452","article-title":"Updates on global epidemiology, risk and prognostic factors of gastric cancer.","volume":"29","author":"Yang","year":"2023","journal-title":"World J Gastroenterol"},{"key":"R3-20260807","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1158\/1055-9965.EPI-13-1057","article-title":"Gastric cancer: descriptive epidemiology, risk factors, screening, and prevention.","volume":"23","author":"Karimi","year":"2014","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"R4-20260807","doi-asserted-by":"crossref","first-page":"783923","DOI":"10.1155\/2012\/783923","article-title":"Clinical distribution and molecular basis of Traditional Chinese Medicine ZHENG in cancer.","volume":"2012","author":"Chen","year":"2012","journal-title":"Evid Based Complement Alternat Med"},{"key":"R5-20260807","first-page":"169","article-title":"Clinical antitumor application and pharmacological mechanisms of Dahuang Zhechong Pill.","volume":"15","author":"Tian","year":"2023","journal-title":"Chin Herb Med"},{"key":"R6-20260807","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1186\/s12906-023-04084-8","article-title":"Network pharmacology prediction and experimental verification of Rhubarb-Peach Kernel promoting apoptosis in endometriosis.","volume":"23","author":"Liao","year":"2023","journal-title":"BMC Complement Med Ther"},{"key":"R7-20260807","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/s13020-017-0158-5","article-title":"Advances in bio-active constituents, pharmacology and clinical applications of Rhubarb.","volume":"12","author":"Cao","year":"2017","journal-title":"Chin Med"},{"key":"R8-20260807","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1186\/s13020-020-00370-6","article-title":"What we already know about Rhubarb: a comprehensive review.","volume":"15","author":"Xiang","year":"2020","journal-title":"Chin Med"},{"key":"R9-20260807","doi-asserted-by":"crossref","first-page":"528308","DOI":"10.3389\/fphar.2020.528308","article-title":"A network pharmacology approach to investigate the anticancer mechanism and potential active ingredients of Rheum palmatum L. against lung cancer via induction of apoptosis.","volume":"11","author":"Zhang","year":"2020","journal-title":"Front Pharmacol"},{"key":"R10-20260807","doi-asserted-by":"crossref","first-page":"1741679","DOI":"10.3389\/fphar.2025.1741679","article-title":"Aloe-emodin: from pharmacological mechanisms to clinical applications and future perspectives.","volume":"16","author":"Xie","year":"2025","journal-title":"Front Pharmacol"},{"key":"R11-20260807","doi-asserted-by":"crossref","first-page":"3887","DOI":"10.7314\/APJCP.2015.16.9.3887","article-title":"Effects of aloe-emodin and emodin on proliferation of the MKN45 human gastric cancer cell line.","volume":"16","author":"Chihara","year":"2015","journal-title":"Asian Pac J Cancer Prev"},{"key":"R12-20260807","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1055\/a-0955-5876","article-title":"Evaluation of anti-inflammatory, antinociceptive, and antipyretic activities of Prunus persica var. nucipersica (nectarine) kernel.","volume":"85","author":"Elshamy","year":"2019","journal-title":"Planta Med"},{"key":"R13-20260807","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/s12906-019-2437-4","article-title":"The anti-proliferative effect of apricot and peach kernel extracts on human colon cancer cells in vitro.","volume":"19","author":"Cassiem","year":"2019","journal-title":"BMC Complement Altern Med"},{"key":"R14-20260807","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1016\/j.jnutbio.2014.03.001","article-title":"Polyphenolics from peach (Prunus persica var. Rich Lady) inhibit tumor growth and metastasis of MDA-MB-435 breast cancer cells in vivo.","volume":"25","author":"Noratto","year":"2014","journal-title":"J Nutr Biochem"},{"key":"R15-20260807","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1016\/j.advnut.2023.05.013","article-title":"\u03b2-Sitosterol as a promising anticancer agent for chemoprevention and chemotherapy: mechanisms of action and future prospects.","volume":"14","author":"Wang","year":"2023","journal-title":"Adv Nutr"},{"key":"R16-20260807","doi-asserted-by":"crossref","first-page":"117586","DOI":"10.1016\/j.taap.2025.117586","article-title":"Hederagenin exerts anti-tumor effects in pancreatic cancer by impairing DRP1 mediated-mitophagy via VDAC1-HK2-PINK1\/PARKIN pathway.","volume":"505","author":"Su","year":"2025","journal-title":"Toxicol Appl Pharmacol"},{"key":"R17-20260807","doi-asserted-by":"crossref","first-page":"587","DOI":"10.2174\/0115734099270389240104050955","article-title":"Molecular mechanism analysis of the effect of hederagenin combined with L-OHP on chemosensitivity of AGS\/L-OHP based on network pharmacology.","volume":"21","author":"Tang","year":"2025","journal-title":"Curr Comput Aided Drug Des"},{"key":"R18-20260807","doi-asserted-by":"crossref","first-page":"110","DOI":"10.3724\/SP.J.1009.2013.00110","article-title":"Traditional Chinese Medicine network pharmacology: theory, methodology and application.","volume":"11","author":"Li","year":"2013","journal-title":"Chin J Nat Med"},{"key":"R19-20260807","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1758-2946-6-13","article-title":"TCMSP: a database of systems pharmacology for drug discovery from herbal medicines.","volume":"6","author":"Ru","year":"2014","journal-title":"J Cheminform"},{"key":"R20-20260807","doi-asserted-by":"crossref","first-page":"6964","DOI":"10.3390\/ijms13066964","article-title":"A novel chemometric method for the prediction of human oral bioavailability.","volume":"13","author":"Xu","year":"2012","journal-title":"Int J Mol Sci"},{"key":"R21-20260807","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.2147\/DDDT.S189088","article-title":"Systematic elucidation of the mechanism of geraniol via network pharmacology.","volume":"13","author":"Zhang","year":"2019","journal-title":"Drug Des Devel Ther"},{"key":"R22-20260807","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jep.2012.09.051","article-title":"Network pharmacology-based prediction of the active ingredients and potential targets of Chinese herbal radix curcumae formula for application to cardiovascular disease.","volume":"145","author":"Tao","year":"2013","journal-title":"J Ethnopharmacol"},{"key":"R23-20260807","doi-asserted-by":"crossref","first-page":"D1265","DOI":"10.1093\/nar\/gkad976","article-title":"DrugBank 6.0: the DrugBank knowledgebase for 2024.","volume":"52","author":"Knox","year":"2024","journal-title":"Nucleic Acids Res"},{"issue":"D1","key":"R24-20260807","doi-asserted-by":"crossref","first-page":"D523","DOI":"10.1093\/nar\/gkac1052","article-title":"UniProt: the universal protein knowledgebase in 2023.","volume":"51","year":"2023","journal-title":"Nucleic Acids Res"},{"key":"R25-20260807","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S0168-9525(97)01103-7","article-title":"GeneCards: integrating information about genes, proteins and diseases.","volume":"13","author":"Rebhan","year":"1997","journal-title":"Trends Genet"},{"key":"R26-20260807","doi-asserted-by":"crossref","first-page":"D789","DOI":"10.1093\/nar\/gku1205","article-title":"OMIM.org: online Mendelian inheritance in man (OMIM\u00ae), an online catalog of human genes and genetic disorders.","volume":"43","author":"Amberger","year":"2015","journal-title":"Nucleic Acids Res"},{"key":"R27-20260807","first-page":"D1031","article-title":"Therapeutic target database 2020: enriched resource for facilitating research and early development of targeted therapeutics.","volume":"48","author":"Wang","year":"2020","journal-title":"Nucleic Acids Res"},{"key":"R28-20260807","doi-asserted-by":"crossref","first-page":"D638","DOI":"10.1093\/nar\/gkac1000","article-title":"The STRING database in 2023: protein-protein association networks and functional enrichment analyses for any sequenced genome of interest.","volume":"51","author":"Szklarczyk","year":"2023","journal-title":"Nucleic Acids Res"},{"key":"R29-20260807","doi-asserted-by":"crossref","first-page":"2498","DOI":"10.1101\/gr.1239303","article-title":"Cytoscape: a software environment for integrated models of biomolecular interaction networks.","volume":"13","author":"Shannon","year":"2003","journal-title":"Genome Res"},{"key":"R30-20260807","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.biosystems.2014.11.005","article-title":"CytoNCA: a cytoscape plugin for centrality analysis and evaluation of protein interaction networks.","volume":"127","author":"Tang","year":"2015","journal-title":"Biosystems"},{"key":"R31-20260807","doi-asserted-by":"crossref","first-page":"e1000350","DOI":"10.1371\/journal.pcbi.1000350","article-title":"Information flow analysis of interactome networks.","volume":"5","author":"Missiuro","year":"2009","journal-title":"PLoS Comput Biol"},{"key":"R32-20260807","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/s11693-013-9123-5","article-title":"The organisational structure of protein networks: revisiting the centrality-lethality hypothesis.","volume":"8","author":"Raman","year":"2014","journal-title":"Syst Synth Biol"},{"key":"R33-20260807","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1038\/nprot.2008.211","article-title":"Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources.","volume":"4","author":"Huang","year":"2008","journal-title":"Nat Protoc"},{"key":"R34-20260807","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1007\/978-1-4939-7000-1_26","article-title":"Protein Data Bank (PDB): the single global macromolecular structure archive.","volume":"1607","author":"Burley","year":"2017","journal-title":"Methods Mol Biol"},{"key":"R35-20260807","doi-asserted-by":"crossref","first-page":"5211","DOI":"10.1021\/jf803878n","article-title":"\u03b2-Sitosterol inhibits cell growth and induces apoptosis in SGC-7901 human stomach cancer cells.","volume":"57","author":"Zhao","year":"2009","journal-title":"J Agric Food Chem"},{"key":"R36-20260807","doi-asserted-by":"crossref","first-page":"8870","DOI":"10.1002\/fsn3.4380","article-title":"\u03b2-Sitosterol-dietary sources and role in cancer and diabetes management.","volume":"12","author":"Adhimoolam","year":"2024","journal-title":"Food Sci Nutr"},{"key":"R37-20260807","doi-asserted-by":"crossref","first-page":"106964","DOI":"10.1016\/j.prostaglandins.2025.106964","article-title":"Beta-sitosterol regulates PTGS1 to inhibit gastric cancer cell proliferation and angiogenesis.","volume":"177","author":"Wang","year":"2025","journal-title":"Prostaglandins Other Lipid Mediat"},{"key":"R38-20260807","doi-asserted-by":"crossref","first-page":"2296","DOI":"10.1016\/j.fct.2007.06.005","article-title":"Aloe-emodin-induced apoptosis in human gastric carcinoma cells.","volume":"45","author":"Chen","year":"2007","journal-title":"Food Chem Toxicol"},{"key":"R39-20260807","first-page":"2953","article-title":"Stilbenes contribute to the anticancer effects of Rheum undulatum L. through activation of apoptosis.","volume":"17","author":"Trinh","year":"2019","journal-title":"Oncol Lett"},{"key":"R40-20260807","first-page":"212","article-title":"Effects of hederagenin on the proliferation, adhesion, invasion, and migration of gastric cancer MGC-803 cells.","volume":"19","author":"Liu","year":"2013","journal-title":"Chin J Exp Tradit Med Form"},{"key":"R41-20260807","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1038\/cdd.2017.187","article-title":"Relevance of the p53-MDM2 axis to aging.","volume":"25","author":"Wu","year":"2018","journal-title":"Cell Death Differ"},{"key":"R42-20260807","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1038\/s41568-021-00412-7","article-title":"Mapping the genomic diaspora of gastric cancer.","volume":"22","author":"Yeoh","year":"2022","journal-title":"Nat Rev Cancer"},{"key":"R43-20260807","doi-asserted-by":"crossref","first-page":"626","DOI":"10.3390\/ijms22020626","article-title":"Upregulation of LAMB1 via ERK\/c-Jun axis promotes gastric cancer growth and motility.","volume":"22","author":"Lee","year":"2021","journal-title":"Int J Mol Sci"},{"key":"R44-20260807","doi-asserted-by":"crossref","first-page":"2365","DOI":"10.1038\/sj.onc.1204443","article-title":"Jun, the oncoprotein.","volume":"20","author":"Vogt","year":"2001","journal-title":"Oncogene"},{"key":"R45-20260807","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.3892\/mmr.2014.2438","article-title":"Raltitrexed induces mitochondrial\u2011mediated apoptosis in SGC7901 human gastric cancer cells.","volume":"10","author":"Xue","year":"2014","journal-title":"Mol Med Rep"},{"key":"R46-20260807","doi-asserted-by":"crossref","first-page":"5651","DOI":"10.1002\/cam4.2440","article-title":"HOXA10 induces BCL2 expression, inhibits apoptosis, and promotes cell proliferation in gastric cancer.","volume":"8","author":"Song","year":"2019","journal-title":"Cancer Med"},{"key":"R47-20260807","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1186\/s12943-023-01857-0","article-title":"Combined inhibition of Bcl-2 family members and YAP induces synthetic lethality in metastatic gastric cancer with RASA1 and NF2 deficiency.","volume":"22","author":"Kwon","year":"2023","journal-title":"Mol Cancer"},{"key":"R48-20260807","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1038\/s41388-022-02575-5","article-title":"A synergistic partnership between IL-33\/ST2 and Wnt pathway through Bcl-xL drives gastric cancer stemness and metastasis.","volume":"42","author":"Kwon","year":"2023","journal-title":"Oncogene"},{"key":"R49-20260807","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1038\/nature13480","article-title":"Comprehensive molecular characterization of gastric adenocarcinoma.","volume":"513","year":"2014","journal-title":"Nature"},{"key":"R50-20260807","doi-asserted-by":"crossref","first-page":"115073","DOI":"10.1016\/j.biopha.2023.115073","article-title":"Estradiol cypionate inhibits proliferation and promotes apoptosis of gastric cancer by regulating AKT ubiquitination.","volume":"165","author":"Qiu","year":"2023","journal-title":"Biomed Pharmacother"},{"key":"R51-20260807","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/S0140-6736(10)61121-X","article-title":"Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial.","volume":"376","author":"Bang","year":"2010","journal-title":"Lancet"},{"key":"R52-20260807","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S0140-6736(21)00797-2","article-title":"First-line nivolumab plus chemotherapy versus chemotherapy alone for advanced gastric, gastro-oesophageal junction, and oesophageal adenocarcinoma (CheckMate 649): a randomised, open-label, phase 3 trial.","volume":"398","author":"Janjigian","year":"2021","journal-title":"Lancet"},{"key":"R53-20260807","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1016\/S0140-6736(23)00620-7","article-title":"Zolbetuximab plus mFOLFOX6 in patients with CLDN18.2-positive, HER2-negative, untreated, locally advanced unresectable or metastatic gastric or gastro-oesophageal junction adenocarcinoma (SPOTLIGHT): a multicentre, randomised, double-blind, phase 3 trial.","volume":"401","author":"Shitara","year":"2023","journal-title":"Lancet"},{"key":"R54-20260807","doi-asserted-by":"crossref","first-page":"2133","DOI":"10.1038\/s41591-023-02465-7","article-title":"Zolbetuximab plus CAPOX in CLDN18.2-positive gastric or gastroesophageal junction adenocarcinoma: the randomized, phase 3 GLOW trial.","volume":"29","author":"Shah","year":"2023","journal-title":"Nat Med"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000050153","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T20:02:23Z","timestamp":1786132943000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000050153"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,7]]},"references-count":54,"journal-issue":{"issue":"32","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000050153","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,7]]},"assertion":[{"value":"2024-11-12","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-07-27","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}